Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity

A series of aldose reductase (ALR2) inhibitors based on pyridothiadiazine were prepared and evaluated for their activities in ALR2 inhibition, DPPH scavenging, and MDA inhibition. Comparison studies were carried out between analogs having either hydroxyl or methoxy groups substituted on the N2-benzy...

Full description

Saved in:
Bibliographic Details
Published inJournal of enzyme inhibition and medicinal chemistry Vol. 31; no. sup1; pp. 126 - 130
Main Authors Zhu, Shaojuan, Zhang, Shuzhen, Hao, Xin, Qin, Xiangyu, Parveen, Shagufta, Yang, Shaoqi, Ma, Bing, Zhu, Changjin
Format Journal Article
LanguageEnglish
Published ABINGDON Taylor & Francis 01.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of aldose reductase (ALR2) inhibitors based on pyridothiadiazine were prepared and evaluated for their activities in ALR2 inhibition, DPPH scavenging, and MDA inhibition. Comparison studies were carried out between analogs having either hydroxyl or methoxy groups substituted on the N2-benzyl side chains of the compounds. Most of the hydroxy-substituted compounds were found to be more potent compared to their methoxy-substituted analogs with respect to DPPH inhibition (>93%) and MDA inhibition (>73%). However, ALR2 inhibitory activity was found to be affected by the electron-withdrawing substituent at the C7 position in addition to the effect of the N2-substituted benzyl group. These results provide an array of multifunctional ALR2 inhibitors possessing capacities both for ALR2 inhibition and as antioxidants.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1475-6366
1475-6374
DOI:10.1080/14756366.2016.1178638